Health Information Technology Advisory Committee 2021 Schedule of Meetings, 73283-73284 [2020-25261]
Download as PDF
<![CDATA[
Federal Register / Vol. 85, No. 222 / Tuesday, November 17, 2020 / Notices
na4.adobeconnect.com/content/
connect/c1/841425677/en/events/event/
shared/1840895551/event_
landing.html?sco-id=1840508041&_
charset_=utf-8. After registering, you
will receive an email confirmation with
a personalized link to access the
webcast on December 2, 2020.
The public will have an opportunity
to present their views to the TBDWG
orally during the meeting’s public
comment session or by submitting a
written public comment. Comments
should be pertinent to the meeting
discussion. Persons who wish to
provide verbal or written public
comment should review instructions at
https://www.hhs.gov/ash/advisorycommittees/tickbornedisease/meetings/
2020-12-2/ and respond by
midnight November 24, 2020, ET.
Verbal comments will be limited to
three minutes each to accommodate as
many speakers as possible during the 30
minute session. Written public
comments will be accessible to the
public on the TBDWG web page prior to
the meeting.
Background and Authority: The TickBorne Disease Working Group was
established on August 10, 2017, in
accordance with Section 2062 of the
21st Century Cures Act, and the Federal
Advisory Committee Act, 5 U.S.C. App.,
as amended, to provide expertise and
review Federal efforts related to all tickborne diseases, to help ensure
interagency coordination and minimize
overlap, and to examine research
priorities. The TBDWG is required to
submit a report to the HHS Secretary
and Congress on their findings and any
recommendations for the Federal
response to tick-borne disease every two
years.
Dated: November 10, 2020.
B. Kaye Hayes,
Acting Director, Office of Infectious Disease
and HIV/AIDS Policy.
[FR Doc. 2020–25312 Filed 11–16–20; 8:45 am]
BILLING CODE 4150–28–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Health Information Technology
Advisory Committee 2021 Schedule of
Meetings
Office of the National
Coordinator for Health Information
Technology (ONC), HHS.
ACTION: Notice of meetings.
AGENCY:
VerDate Sep<11>2014
19:46 Nov 16, 2020
Jkt 253001
Composition
The HITAC is comprised of at least 25
members, of which:
• No fewer than 2 members are
advocates for patients or consumers of
health information technology;
• 3 members are appointed by the
HHS Secretary
Æ 1 of whom shall be appointed to
represent the Department of Health and
Human Services and
Æ 1 of whom shall be a public health
official;
• 2 members are appointed by the
majority leader of the Senate;
• 2 members are appointed by the
minority leader of the Senate;
• 2 members are appointed by the
Speaker of the House of Representatives;
• 2 members are appointed by the
minority leader of the House of
Representatives; and
• Other members are appointed by
the Comptroller General of the United
States.
Members will serve for one-, two-, or
three-year terms. All members may be
reappointed for a subsequent three-year
term. Each member is limited to two
three-year terms, not to exceed six years
of service. Members serve without pay,
but will be provided per-diem and
travel costs for committee services, if
warranted.
Recommendations
The Health Information
Technology Advisory Committee
(HITAC) was established in accordance
with the 21st Century Cures Act and the
SUMMARY:
Federal Advisory Committee Act. The
HITAC, among other things, identifies
priorities for standards adoption and
makes recommendations to the National
Coordinator for Health Information
Technology (National Coordinator). The
HITAC will hold public meetings
throughout 2021. See list of public
meetings below.
FOR FURTHER INFORMATION CONTACT:
Lauren Richie, Designated Federal
Officer, at Lauren.Richie@hhs.gov, (202)
205–7674.
SUPPLEMENTARY INFORMATION: Section
4003(e) of the 21st Century Cures Act
(Pub. L. 114–255) establishes the Health
Information Technology Advisory
Committee (referred to as the ‘‘HITAC’’).
The HITAC will be governed by the
provisions of the Federal Advisory
Committee Act (FACA) (Pub. L. 92–
463), as amended, (5 U.S.C. App.),
which sets forth standards for the
formation and use of federal advisory
committees.
The HITAC recommendations to the
National Coordinator are publicly
available at https://www.healthit.gov/
topic/federal-advisory-committees/
recommendations-national-coordinatorhealth-it.
PO 00000
Frm 00026
Fmt 4703
Sfmt 4703
73283
Public Meetings
The schedule of meetings to be held
in 2021 is as follows:
• January 13, 2021 from approximately
9:30 a.m. to 2:30 p.m./Eastern Time
(virtual meeting)
• February 10, 2021 from approximately
9:30 a.m. to 2:30 p.m./Eastern Time
(virtual meeting)
• April 15, 2021 from approximately
9:30 a.m. to 2:30 p.m./Eastern Time
(virtual meeting)
• May 13, 2021 from approximately
9:30 a.m. to 2:30 p.m./Eastern Time
(virtual meeting)
• June 9, 2021 from approximately 9:30
a.m. to 2:30 p.m./Eastern Time
(virtual meeting)
• July 14, 2021 from approximately 9:30
a.m. to 2:30 p.m./Eastern Time
(virtual meeting)
• September 9, 2021 from
approximately 9:30 a.m. to 2:30
p.m./Eastern Time (virtual meeting)
• November 10, 2021 from
approximately 9:30 a.m. to 2:30
p.m./Eastern Time (virtual meeting)
All meetings are open to the public.
Additional meetings may be scheduled
as needed. For web conference
instructions and the most up-to-date
information, please visit the HITAC
calendar on the ONC website, https://
www.healthit.gov/topic/federaladvisory-committees/hitac-calendar.
Contact Person for Meetings: Lauren
Richie, Lauren.Richie@hhs.gov. A notice
in the Federal Register about last
minute modifications that impact a
previously announced advisory
committee meeting cannot always be
published quickly enough to provide
timely notice. Please email Lauren
Richie for the most current information
about meetings.
Agenda: As outlined in the 21st
Century Cures Act, the HITAC will
develop and submit recommendations
to the National Coordinator on the
topics of interoperability, privacy and
security, and patient access. In addition,
the committee will also address any
administrative matters and hear
periodic reports from ONC. ONC
intends to make background material
available to the public no later than 24
hours prior to the meeting start time. If
ONC is unable to post the background
material on its website prior to the
meeting, the material will be made
publicly available on ONC’s website
after the meeting, at https://
www.healthit.gov/hitac.
Procedure: Interested persons may
present data, information, or views,
orally or in writing, on issues pending
before the committee. Written
submissions may be made to the contact
E:\FR\FM\17NON1.SGM
17NON1
73284
Federal Register / Vol. 85, No. 222 / Tuesday, November 17, 2020 / Notices
person prior to the meeting date. An
oral public comment period will be
scheduled at each meeting. Time
allotted for each commenter will be
limited to three minutes. If the number
of speakers requesting to comment is
greater than can be reasonably
accommodated during the scheduled
public comment period, ONC will take
written comments after the meeting.
Persons attending in-person HITAC
meetings are advised that the agency is
not responsible for providing wireless
access or access to electrical outlets.
ONC welcomes the attendance of the
public at its HITAC meetings. Seating is
limited at in-person meetings, and ONC
will make every effort to accommodate
persons with physical disabilities or
special needs. If you require special
accommodations due to a disability,
please contact Lauren Richie at least
seven (7) days in advance of the
meeting.
Notice of these meetings are given
under the Federal Advisory Committee
Act (Pub. L. 92–463, 5 U.S.C., App. 2).
Dated: November 9, 2020.
Lauren Richie,
Designated Federal Officer, Office of the
National Coordinator for Health Information
Technology.
[FR Doc. 2020–25261 Filed 11–16–20; 8:45 am]
BILLING CODE 4150–45–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Population Science and
Epidemiology B.
Date: December 8, 2020.
Time: 10:00 a.m. to 3:30 p.m.
Agenda: To review and evaluate grant
applications.
VerDate Sep<11>2014
19:46 Nov 16, 2020
Jkt 253001
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Lisa Steele, Ph.D.,
Scientific Review Officer, PSE IRG, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3139,
MSC 7770, Bethesda, MD 20892, (301) 594–
6594, steeleln@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Cancer Prevention and Mechanisms
of Cancer Therapeutics.
Date: December 8, 2020.
Time: 1:00 p.m. to 3:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Telephone Conference
Call).
Contact Person: Lawrence Ka-Yun Ng,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6152,
MSC 7804, Bethesda, MD 20892, (301) 435–
1719, ngkl@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel;
Hypersensitivity and Mucosal Immunology
Mechanisms.
Date: December 9, 2020.
Time: 2:00 p.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Deborah Hodge, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4207,
MSC 7812, Bethesda, MD 20892, (301) 435–
1238, hodged@mail.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel;
Biostatistical Methods and Research Design.
Date: December 10, 2020.
Time: 1:30 p.m. to 3:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Lisa Steele, Ph.D.,
Scientific Review Officer, PSE IRG, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3139,
MSC 7770, Bethesda, MD 20892, (301) 594–
6594, steeleln@csr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: November 10, 2020.
Miguelina Perez,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2020–25285 Filed 11–16–20; 8:45 am]
BILLING CODE 4140–01–P
PO 00000
Frm 00027
Fmt 4703
Sfmt 4703
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of a
meeting of the National Cancer
Advisory Board and NCI Board of
Scientific Advisors.
The meeting will be held as a virtual
meeting and is open to the public as
indicated below. Individuals who plan
to view the virtual meeting and need
special assistance or other reasonable
accommodations to view the meeting,
should notify the Contact Person listed
below in advance of the meeting. The
meeting will be videocast and can be
accessed from the NIH Videocasting and
Podcasting website (https://
videocast.nih.gov/).
A portion of the National Cancer
Advisory Board meeting will be closed
to the public in accordance with the
provisions set forth in section
552b(c)(6), Title 5 U.S.C., as amended.
The intramural programs and projects
and the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the
intramural programs and projects, the
disclosure of which would constitute a
clearly unwarranted invasion of
personal privacy.
Name of Committee: National Cancer
Advisory Board and NCI Board of Scientific
Advisors.
Date: November 30, 2020.
Closed: 12:00 p.m. to 1:00 p.m.
Agenda: Review of intramural program site
visit outcomes and the discussion of
confidential personnel issues.
Open: 1:15 p.m. to 4:45 p.m.
Agenda: NCAB Subcommittee Meetings—
Subcommittee on Planning and Budget; Ad
Hoc Subcommittee on Experimental
Therapeutics; and Ad Hoc Subcommittee on
Population Science, Epidemiology and
Disparities.
Place: National Cancer Institute—Shady
Grove, 9609 Medical Center Drive, Rockville,
MD 20850 (Virtual Meeting).
Name of Committee: National Cancer
Advisory Board and NCI Board of Scientific
Advisors.
Date: December 1, 2020.
Open: 1:00 p.m. to 5:00 p.m.
Agenda: Joint meeting of the National
Cancer Advisory Board and NCI Board of
Scientific Advisors, NCI Director’s report and
presentations, NCI Board of Scientific
Advisors Concepts Review.
Place: National Cancer Institute—Shady
Grove, 9609 Medical Center Drive, Rockville,
MD 20850 (Virtual Meeting).
E:\FR\FM\17NON1.SGM
17NON1
]]>Agencies
[Federal Register Volume 85, Number 222 (Tuesday, November 17, 2020)]
[Notices]
[Pages 73283-73284]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-25261]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Health Information Technology Advisory Committee 2021 Schedule of
Meetings
AGENCY: Office of the National Coordinator for Health Information
Technology (ONC), HHS.
ACTION: Notice of meetings.
-----------------------------------------------------------------------
SUMMARY: The Health Information Technology Advisory Committee (HITAC)
was established in accordance with the 21st Century Cures Act and the
Federal Advisory Committee Act. The HITAC, among other things,
identifies priorities for standards adoption and makes recommendations
to the National Coordinator for Health Information Technology (National
Coordinator). The HITAC will hold public meetings throughout 2021. See
list of public meetings below.
FOR FURTHER INFORMATION CONTACT: Lauren Richie, Designated Federal
Officer, at [email protected], (202) 205-7674.
SUPPLEMENTARY INFORMATION: Section 4003(e) of the 21st Century Cures
Act (Pub. L. 114-255) establishes the Health Information Technology
Advisory Committee (referred to as the ``HITAC''). The HITAC will be
governed by the provisions of the Federal Advisory Committee Act (FACA)
(Pub. L. 92-463), as amended, (5 U.S.C. App.), which sets forth
standards for the formation and use of federal advisory committees.
Composition
The HITAC is comprised of at least 25 members, of which:
No fewer than 2 members are advocates for patients or
consumers of health information technology;
3 members are appointed by the HHS Secretary
[cir] 1 of whom shall be appointed to represent the Department of
Health and Human Services and
[cir] 1 of whom shall be a public health official;
2 members are appointed by the majority leader of the
Senate;
2 members are appointed by the minority leader of the
Senate;
2 members are appointed by the Speaker of the House of
Representatives;
2 members are appointed by the minority leader of the
House of Representatives; and
Other members are appointed by the Comptroller General of
the United States.
Members will serve for one-, two-, or three-year terms. All members
may be reappointed for a subsequent three-year term. Each member is
limited to two three-year terms, not to exceed six years of service.
Members serve without pay, but will be provided per-diem and travel
costs for committee services, if warranted.
Recommendations
The HITAC recommendations to the National Coordinator are publicly
available at https://www.healthit.gov/topic/federal-advisory-committees/recommendations-national-coordinator-health-it.
Public Meetings
The schedule of meetings to be held in 2021 is as follows:
January 13, 2021 from approximately 9:30 a.m. to 2:30 p.m./
Eastern Time (virtual meeting)
February 10, 2021 from approximately 9:30 a.m. to 2:30 p.m./
Eastern Time (virtual meeting)
April 15, 2021 from approximately 9:30 a.m. to 2:30 p.m./
Eastern Time (virtual meeting)
May 13, 2021 from approximately 9:30 a.m. to 2:30 p.m./Eastern
Time (virtual meeting)
June 9, 2021 from approximately 9:30 a.m. to 2:30 p.m./Eastern
Time (virtual meeting)
July 14, 2021 from approximately 9:30 a.m. to 2:30 p.m./
Eastern Time (virtual meeting)
September 9, 2021 from approximately 9:30 a.m. to 2:30 p.m./
Eastern Time (virtual meeting)
November 10, 2021 from approximately 9:30 a.m. to 2:30 p.m./
Eastern Time (virtual meeting)
All meetings are open to the public. Additional meetings may be
scheduled as needed. For web conference instructions and the most up-
to-date information, please visit the HITAC calendar on the ONC
website, https://www.healthit.gov/topic/federal-advisory-committees/hitac-calendar.
Contact Person for Meetings: Lauren Richie, [email protected].
A notice in the Federal Register about last minute modifications that
impact a previously announced advisory committee meeting cannot always
be published quickly enough to provide timely notice. Please email
Lauren Richie for the most current information about meetings.
Agenda: As outlined in the 21st Century Cures Act, the HITAC will
develop and submit recommendations to the National Coordinator on the
topics of interoperability, privacy and security, and patient access.
In addition, the committee will also address any administrative matters
and hear periodic reports from ONC. ONC intends to make background
material available to the public no later than 24 hours prior to the
meeting start time. If ONC is unable to post the background material on
its website prior to the meeting, the material will be made publicly
available on ONC's website after the meeting, at https://www.healthit.gov/hitac.
Procedure: Interested persons may present data, information, or
views, orally or in writing, on issues pending before the committee.
Written submissions may be made to the contact
[[Page 73284]]
person prior to the meeting date. An oral public comment period will be
scheduled at each meeting. Time allotted for each commenter will be
limited to three minutes. If the number of speakers requesting to
comment is greater than can be reasonably accommodated during the
scheduled public comment period, ONC will take written comments after
the meeting.
Persons attending in-person HITAC meetings are advised that the
agency is not responsible for providing wireless access or access to
electrical outlets.
ONC welcomes the attendance of the public at its HITAC meetings.
Seating is limited at in-person meetings, and ONC will make every
effort to accommodate persons with physical disabilities or special
needs. If you require special accommodations due to a disability,
please contact Lauren Richie at least seven (7) days in advance of the
meeting.
Notice of these meetings are given under the Federal Advisory
Committee Act (Pub. L. 92-463, 5 U.S.C., App. 2).
Dated: November 9, 2020.
Lauren Richie,
Designated Federal Officer, Office of the National Coordinator for
Health Information Technology.
[FR Doc. 2020-25261 Filed 11-16-20; 8:45 am]
BILLING CODE 4150-45-P
